Lightchain Capital

Lightchain Capital is a venture capital firm based in Saint Louis, Missouri, founded in 2018. The firm specializes in investing in early-stage life sciences companies, particularly those focused on improving patient outcomes in cancer treatment. In addition to its primary focus on life sciences, Lightchain Capital also explores opportunities within the software sector, aiming to support innovative solutions that can enhance healthcare delivery and outcomes.

Drew Dennison

Managing Director

Rodger Riney

Founder

3 past transactions

SimpleRose

Venture Round in 2023
SimpleRose Inc. develops and operates optimal decision-making platform. The company's product enables optimal decision-making in complex world where the proliferation of data and growing scope of organizations. The company was incorporated in 2018 and is headquartered in Saint Louis, Missouri.

NextRNA

Series A in 2022
NextRNA Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2020. The company focuses on developing targeted therapeutics by discovering novel non-coding ribonucleic acids (ncRNAs) linked to various diseases. Utilizing an innovative discovery platform, NextRNA identifies and modulates RNA-binding proteins associated with disease functions of ncRNAs. This approach aims to disrupt the interactions between disease-related ncRNAs and their protein partners, thereby enabling medical practitioners to address and potentially cure a range of diseases.

SimpleRose

Venture Round in 2018
SimpleRose Inc. develops and operates optimal decision-making platform. The company's product enables optimal decision-making in complex world where the proliferation of data and growing scope of organizations. The company was incorporated in 2018 and is headquartered in Saint Louis, Missouri.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.